Precision oncology: separating the wheat from the chaff

被引：31
|
作者：
Remon, Jordi [1 ]
Dienstmann, Rodrigo [2 ]
机构：
[1] HM Delfos, Ctr Integral Oncol Clara Campal Barcelona, Med Oncol Dept, Barcelona, Spain
[2] Hosp Valle De Hebron, Oncol Data Sci ODysSey Grp, Barcelona, Spain
来源：
ESMO OPEN | 2018年 / 3卷 / 06期
关键词：
CELL LUNG-CANCER; METASTATIC BREAST-CANCER; OPEN-LABEL; MOLECULAR CHARACTERIZATION; ANTICANCER DRUGS; TARGETED THERAPY; FDA APPROVAL; SOLID TUMORS; PHASE-II; MEDICINE;
D O I：
10.1136/esmoopen-2018-000446
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Precision oncology based on next-generation sequencing (NGS) test is growing in daily clinical practice. However, the real impact of this strategy in patients' outcome on a large scale remains uncertain. In this review, we summarise existing literature on this topic, limitations for broad NGS implementation, bottlenecks in genomic variant interpretation and the role of molecular tumour boards.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Precision Oncology Targets in Biliary Tract Cancer
    Farha, Nicole
    Dima, Danai
    Ullah, Fauzia
    Kamath, Suneel
    CANCERS, 2023, 15 (07)
  • [2] Harnessing Solute Carrier Transporters for Precision Oncology
    Nyquist, Michael D.
    Prasad, Bhagwat
    Mostaghel, Elahe A.
    MOLECULES, 2017, 22 (04):
  • [3] Genomics and the History of Precision Oncology
    Doroshow, Deborah B.
    Doroshow, James H.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 29 (01) : 35 - +
  • [4] Variant classification in precision oncology
    Leichsenring, Jonas
    Horak, Peter
    Kreutzfeldt, Simon
    Heining, Christoph
    Christopoulos, Petros
    Volckmar, Anna-Lena
    Neumann, Olaf
    Kirchner, Martina
    Ploeger, Carolin
    Budczies, Jan
    Heilig, Christoph E.
    Hutter, Barbara
    Froehlich, Martina
    Uhrig, Sebastian
    Kazdal, Daniel
    Allgaeuer, Michael
    Harms, Alexander
    Rempel, Eugen
    Lehmann, Ulrich
    Thomas, Michael
    Pfarr, Nicole
    Azoitei, Ninel
    Bonzheim, Irina
    Marienfeld, Ralf
    Moeller, Peter
    Werner, Martin
    Fend, Falko
    Boerries, Melanie
    von Bubnoff, Nikolas
    Lassmann, Silke
    Longerich, Thomas
    Bitzer, Michael
    Seufferlein, Thomas
    Malek, Nisar
    Weichert, Wilko
    Schirmacher, Peter
    Penzel, Roland
    Endris, Volker
    Brors, Benedikt
    Klauschen, Frederick
    Glimm, Hanno
    Frhoeling, Stefan
    Stenzinger, Albrecht
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (11) : 2996 - 3010
  • [5] Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards
    Fujiwara, Yu
    Kato, Shumei
    Kurzrock, Razelle
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (02) : 197 - 216
  • [6] Precision Oncology in Hepatopancreatobiliary Cancer Surgery
    Newhook, Timothy E.
    Tsai, Susan
    Meric-Bernstam, Funda
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (02) : 343 - 367
  • [7] Top advances of the year: Precision oncology
    Desai, Aakash
    Reddy, Neha K.
    Subbiah, Vivek
    CANCER, 2023, 129 (11) : 1634 - 1642
  • [8] Debunking the Delusion That Precision Oncology Is an Illusion
    Subbiah, Vivek
    Kurzrock, Razelle
    ONCOLOGIST, 2017, 22 (08) : 881 - 882
  • [9] Addressing the challenges of applying precision oncology
    Shin, Seung Ho
    Bode, Ann M.
    Dong, Zigang
    NPJ PRECISION ONCOLOGY, 2017, 1
  • [10] Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting
    Sultova, Elena
    Westphalen, C. Benedikt
    Jung, Andreas
    Kumbrink, Joerg
    Kirchner, Thomas
    Mayr, Doris
    Rudelius, Martina
    Ormanns, Steffen
    Heinemann, Volker
    Metzeler, Klaus H.
    Greif, Philipp A.
    Hester, Anna
    Mahner, Sven
    Harbeck, Nadia
    Wuerstlein, Rachel
    DIAGNOSTICS, 2021, 11 (04)
12345